Skip to main content

It looks like you are visiting from outside the EU. Switch to the US version to see local pricing in USD and local shipping.

Switch to US ($)
Contact +33 (0)3 90 20 54 70

📢 ProteoGenix Loyalty Program is live — Earn points on every online order. Discover the program

Get 25% off your first bioreagent online order — use code: PROTEOSHOP25
Brand: ProteoGenix

Trastuzumab Biosimilar Antibody (Anti-HER2)

Isotype:
IgG1

€120.00

100ug + 120 loyalty points
Size
Clear
  • In Stock
  • Free shipping in EU on orders > €500
  • Wide range of unique reagents
  • Fast worldwide delivery
CD340 Recombinant Protein binds to Trastuzumab Biosimilar - Anti-HER2 mAb in indirect ELISA assay
SDS-PAGE for Trastuzumab Biosimilar - Anti-HER2 mAb - Research Grade

Trastuzumab Biosimilar Antibody (Anti-HER2)

Product name Trastuzumab Biosimilar Antibody (Anti-HER2)
Source DrugBank DB00072 
Species Human
Expression system Mammalian cells
Molecular weight 145kDa
Purity >85%
Buffer PBS pH7.5
Delivery condition Blue ice (+4°C)
Delivery lead time in business days 3-5 days if in stock; 3-5 weeks if production needed
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition 4°C for short term; -20°C for long term
Brand ProteoGenix
Aliases /Synonyms Trastuzumab,Trastuzumab,HER2,anti-HER2
Reference PX-TA1005
Note For research use only. Not suitable for human use.
Isotype IgG1
Product name Trastuzumab Biosimilar Antibody (Anti-HER2)
Source DrugBank DB00072 
Species Human
Expression system Mammalian cells
Molecular weight 145kDa
Purity >85%
Buffer PBS pH7.5
Delivery condition Blue ice (+4°C)
Delivery lead time in business days 3-5 days if in stock; 3-5 weeks if production needed
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition 4°C for short term; -20°C for long term
Brand ProteoGenix
Aliases /Synonyms Trastuzumab,Trastuzumab,HER2,anti-HER2
Reference PX-TA1005
Note For research use only. Not suitable for human use.
Isotype IgG1
Product name Trastuzumab Biosimilar - Anti-HER2 mAb - Research Grade
Source DrugBank DB00072 
Species Human
Expression system Mammalian cells
Molecular weight 145kDa
Purity >85%
Buffer PBS pH7.5
Delivery condition Blue ice (+4°C)
Delivery lead time in business days 3-5 days if in stock; 3-5 weeks if production needed
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition 4°C for short term; -20°C for long term
Brand ProteoGenix
Applications ELISA,WB
Aliases /Synonyms Trastuzumab,Trastuzumab,HER2,anti-HER2
Reference PX-TA1005
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG1
Clonality Monoclonal Antibody
Product name Trastuzumab Biosimilar - Anti-HER2 mAb - Research Grade
Source DrugBank DB00072 
Species Human
Expression system Mammalian cells
Molecular weight 145kDa
Purity >85%
Buffer PBS pH7.5
Delivery condition Blue ice (+4°C)
Delivery lead time in business days 3-5 days if in stock; 3-5 weeks if production needed
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition 4°C for short term; -20°C for long term
Brand ProteoGenix
Applications ELISA,WB,,,
Aliases /Synonyms Trastuzumab,Trastuzumab,HER2,anti-HER2
Reference PX-TA1005
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG1
Clonality Monoclonal Antibody

The trastuzumab biosimilar antibody is a recombinant anti-HER2 monoclonal antibody designed for research applications. HER2 (Human Epidermal Growth Factor Receptor 2) is a transmembrane receptor involved in cell proliferation and signaling pathways, making it a widely studied target in oncology and cell biology.

This trastuzumab biosimilar enables researchers to investigate HER2-mediated signaling, receptor binding, and antibody interactions in controlled experimental settings. It is suitable for laboratories working on antibody characterization, cell-based assays, and oncology-related research.

Biological Background

HER2 belongs to the epidermal growth factor receptor (EGFR) family and plays a key role in regulating cell growth and differentiation. Overexpression of HER2 has been extensively studied in cancer biology, making it an important target in research involving receptor signaling and antibody-based mechanisms.

Trastuzumab antibodies are commonly used in experimental studies to evaluate:

  • HER2 receptor binding and activation
  • antibody–antigen interactions
  • cell signaling pathways
  • oncology and targeted antibody research

Applications

The trastuzumab antibody is suitable for a wide range of research applications, including:

  • ELISA and binding assays
  • cell-based functional assays
  • antibody characterization studies
  • protein–protein interaction analysis
  • oncology and HER2-related research

Related Services

Researchers working with therapeutic antibodies and biosimilars may benefit from ProteoGenix expertise in:

Related Therapeutic Antibodies

Trastuzumab Price and Cost

ProteoGenix offers trastuzumab biosimilar antibodies at competitive market prices, allowing research laboratories to access high-quality reagents while optimizing project budgets.

Our biosimilar antibodies are produced under controlled conditions to ensure consistent quality, reproducibility, and cost-effective use in research applications.

CD340 Recombinant Protein binds to Trastuzumab Biosimilar - Anti-HER2 mAb in indirect ELISA assay

CD340 Recombinant Protein binds to Trastuzumab Biosimilar - Anti-HER2 mAb in indirect ELISA assay

Immobilized CD340 Recombinant Protein (cat. No.PX-P4121) at 0.5µg/mL (100µL/well) can bind Trastuzumab Biosimilar - Anti-HER2 mAb (cat. No.PX-TA1005) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450 giving an EC50 at 662.9M.

SDS-PAGE for Trastuzumab Biosimilar - Anti-HER2 mAb - Research Grade

SDS-PAGE for Trastuzumab Biosimilar - Anti-HER2 mAb - Research Grade

Trastuzumab Biosimilar - Anti-HER2 mAb - Research Grade on SDS-PAGE under reducing and non-reducing conditions. The gel was stained overnight with Coomassie Blue.. The purity of the antibody is greater than 95%.

  • Chemical coupling of biological magnetosomes with amine-functionalized therapeutic antibody conjugates, S.M Payan, L Gandarias, R Avellan, D Faivre, S Prévéral, bioRxiv 2025.02.10.637426; doi: https://doi.org/10.1101/2025.02.10.637426

There are no reviews yet.

Be the first to review “Trastuzumab Biosimilar Antibody (Anti-HER2)”

Your email address will not be published. Required fields are marked *

Related products

Recently viewed products

Loading recently viewed products…

Can’t find what you need?

Our catalog doesn’t cover everything — but our team does. Whether you need a custom antibody, a specific protein variant, or a bulk order, our scientists are here to help.

Contact Our Team Book a Call

Cart (0 Items)

Your cart is currently empty.

View Products